Ravi Salgia, MD, PhD
Professor of Medicine, Pathology and Dermatology
Director, Chest Oncology and Thoracic Oncology Research Program
Vice Chair, Translational Research
Dr. Ravi Salgia is an expert in thoracic oncology. He has clinical expertise in thoracic oncology, and has developed a strong program in novel therapeutics targeting thoracic malignancies. He has been practicing medical oncology with special expertise in thoracic oncology for more than 15 years. Dr. Salgia also consults on national and international cases in thoracic malignancies.
He has defined several novel targets in oncology, and leads a strong clinical and research group. Dr. Salgia is developing potential biomarkers that would be useful for early diagnosis, linkage to prognosis, and therapeutic monitoring in these diseases.
His research includes studying targeted therapies that enhance the quality of life for patients with cancer. Specifically, he and his laboratory identified that targeting the receptor tyrosine kinases are important in lung cancer. Most recently, they identified unique mutations of the receptor tyrosine kinase c-Met. In addition, they have discovered important pathways in heat shock proteins. Dr. Salgia's clinical and research effort is to bring these advanced therapies for patient benefit. His work has been funded by the American Cancer Society, the National Cancer Institute, MARF, and the University of Chicago Research Cancer Center.
Dr. Salgia has published numerous articles in prestigious journals, and has contributed to books related to thoracic malignancies. He is also an associate editor for various journals, and consults in thoracic oncology for Best Doctors.
Duchossois Center for Advanced Medicine
The University of Chicago Medicine
Year Started Practice
Loyola University Stritch School of Medicine
Internship and Residency
Johns Hopkins Hospital, Baltimore
Dana-Farber Cancer Institute/Harvard Medical School
American Association for Cancer Research
Office Postal Address
Ravi Salgia, MD, PhD
Request an appointment online
Physicians, contact the cancer intake line at (773) 702-8222.
More About Dr. Salgia
Learn how Dr. Salgia collaborates with other experts to improve screening and prevention methods for patients at high risk for developing cancers of the upper aerodigestive tract.
View a video presentation of Dr. Salgia's lung cancer talk, "Lung Cancer Research: From Prevention to Cure."
A dedicated educator and mentor, Dr. Salgia delivered a lecture on translational research in lung cancer at a Grand Rounds event in Wisconsin. Watch his presentation.
When Tony Palumbo was faced with "incurable" non-small cell lung cancer, Dr. Salgia created a personalized treatment plan. Thanks to aggressive therapy and a positive approach, Palumbo is now cancer-free.
After Jim Chessare's successful surgery to remove a small mediastinal tumor, he was referred to Dr. Saglia to be evaluated for follow-up care.
Dr. Salgia is implanting human cancer mutations into tiny worms, in order to find out which genes make promising drug targets. Learn more about his work.
View a partial list of Dr. Salgia's publications through the National Library of Medicine's PubMed online database.